Clinical Trial Update: Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating a conditioning regimen of cyclophosphamide, fludarabine, and total-body irradiation followed by cellular adoptive im…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2013-03-27